baber/WOPTO huggingface dataset:
Patent NZ-517600-A (NZ)
Title: Process for the preparation of herbal wines from himalayan berries
Inventor: SINGH HARSH PRATAP
IPC: C12G3/02
Filed: 2001-03-29
Abstract: A process for the preparation of herbal wines from ripe Himalayan berries namely, from ripe berries of Berberis lycium, Pyrus pashia, Actinidia deliciosa and Syzygium jambos comprises: cleaning the ripe berries, soaking the cleaned ripe berries for 30 min to 4 hrs in 0.1 to 1.0 % sodium meta-bi-sulphate water solution, draining the water solution and adding cold boiled water and preparing a berry pulp by mashing the buries, mixing the berry pulp so obtained with boiled sucrose solution so as to obtain the final sucrose concentration of between10-12% and adding yeast nutrient, pectinase enzyme and active yeast comprising a mother yeast culture and cooled green tea infusion into the solution mixture and allowing the solution mixture to ferment under protected atmosphere to avoid any contamination at 17 to30oC and when the first active fermentation of the solution dies down and nears the end of the fermentation, the wine starts clearing which is then siphoned off and bottled in sterilized containers and if desired the content is decanted into another sterile container and a sucrose solution is added to make a final sucrose concentration in the wine of 5%, adding active yeast solution and between 0.1 to 1.0% sodium meta-bi-sulphate, and allowing the contents to ferment for about a month at a temperature between 17 to 30oc followed by siphoning off the wine and storing the wine in sterilized containers.
Patent NZ-518436-A (NZ)
Title: Transdermal drug delivery devices
Inventor: DREYER STEVE J
IPC: A61K31/407
Filed: 2000-10-27
Abstract: Systems and devices for the transdermal delivery of the compound (R)-(Z)-1-azabicyclo[2.2.1]heptan-3-one, 0-[3(3-methoxyphenyl)-2-propynyl]oxime are disclosed. These devices include a drug in adhesive reservoir layer and a skin contacting adhesive layer in which the skin contacting adhesive layer acts as a rate controlling membrane. These devices also include a drug in adhesive reservoir layer and a skin contacting adhesive, where a membrane is placed between the two adhesive layers. The compound is a muscarinic agonist, useful in the treatment of a variety of cognitive disorders, including Alzheimer's Disease.
Patent NZ-526763-A (NZ)
Title: Process and device for formation of mineral wool and mineral wool products
Inventor: TRABBOLD MARK
IPC: C03B37/083
Filed: 2002-02-13
Abstract: Glass fiber insulation products and methods of manufacturing small diameter glass fibers with fewer stress-rising defects are provided. The insulation products can provide the same thermal resistance or R-value with reductions in fiber density of at least about 20% or more while achieving acceptable recovery of the nominal thickness following compression. The methods provided can produce fine diameter glass fibers with fewer defects through a combination of lower attenuating gas velocities and the use of spinners having more and smaller holes. A preferred method uses a device for internal centrifugation of mineral fibers including a centrifuge equipped with a peripheral bland perforated with orifices distributed in a plurality of annular zones arranged on top of each other, assuming that the centrifuge is in centrifugation position.
Patent NZ-526908-A (NZ)
Title: The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
Inventor: HEGELE-HARTUNG CHRISTA
IPC: A61P15/00
Filed: 2002-01-09
Abstract: A method of inhibiting the occurrence of advanced endometrium maturation in a female mammal undergoing fertility treatment is disclosed. The method comprises the administration at least one 17 alpha -fluoralkylated progesterone receptor antagonist to the female mammal.
Patent NZ-527295-A (NZ)
Title: Applicator for delivering a liquid or semi-solid topical formulation into a mucosal cavity, for example, a vagina
Inventor: BERGERON MICHEL G
IPC: A61K9/00
Filed: 1999-04-27
Abstract: Described is a unique vaginal/ano-rectal applicator for the uniform delivery of any topical formulations to treat and/or prevent any infection and/or abnormal conditions of mucosa cavity caused by any pathogen and/or disease. The applicator is illustrated in FIG. 13. A plurality of slots regularly spaced from each other are provided in the external wall. In this specific version, the expulsion element and the reservoir are also one single element. The expulsion element is a piston-like structure (10) that comprises the formulation provided in a pouch (11). In this embodiment, the connector element (5) is telescopically insertable in the piston-like structure (10). The pouch is made of a material of low resistance to compression. To break this membrane, a tapered element is provided at the proximal end of the internal wall. FIG. 13 shows this tapered element (9) as a disc provided with a pointed portion. The disc sits on the proximal end of the internal wall, the pointed portion facing the pouch (11). In use, the piston-like structure (10) is pressed by the user, the membrane is thus pierced by the pointed portion, and the formulation is thus forced through the diffusion channel, and expelled through the perforations. FIG. 13a is a perspective view illustrating an applicator. FIG. 13b is a side elevational view illustrating the dimensions in inches of the applicator of FIG. 13a in both insertion position and actuated position. FIG. 13c is an exploded view of the applicator of FIG. 13a.
Patent NZ-530549-A (NZ)
Title: Education service system using communicate line and education service providing method
Inventor: SARUHASHI NOZOMU
IPC: G06Q50/00
Filed: 2002-06-24
Abstract: An educational service system comprises: material contents storing means for storing multimedia materials of contents that are materials contents to be delivered; scenario storing means for storing a scenario for defining a combination of the material contents along a time axis; and contents delivery means for fetching the material contents stored in the material contents storing means based on the scenario stored in the scenario storing means, and delivering the same to each of the terminals connected to communication lines; independent bidirectional communication means for providing a bidirectional conversation function using TV pictures and sounds between terminals connected to communication lines and one or a plurality of instructor terminals and one or a plurality of student terminals hold a conversation using TV pictures and sounds while the individual terminals are given a presentation using a plurality of material contents in combination.
Patent NZ-530971-A (NZ)
Title: Oral dosage forms comprising an opioid agonist with releasable and sequestered opioid antagonists
Inventor: BREDER CHRISTOPHER
IPC: A61K9/22
Filed: 2002-08-06
Abstract: An oral dosage form comprises a therapeutically effective amount of an opioid agonist, an opioid antagonist in releasable form and a sequestered antagonist which is not released when the dosage form is administrated intact. Preferably the antagonists are selected from naltrexone, naloxone, nalmephene, cyclazocine, levallorphan, and mixtures thereof and the agonist is selected from morphine, hydromorphone, hydrocodone, oxycodone, codeine, levorphanol, tramadol, meperidine, methadone and mixtures thereof. The dosage forms are useful for the treatment of pain.
Patent NZ-532472-A (NZ)
Title: Traffic barrier with liquid filled modules that join end to end and have two attachment means for greater impact resistance
Inventor: DUCKETT JOHN W
IPC: E01F15/08
Filed: 2002-07-23
Abstract: A traffic barrier including a plurality of traffic barrier modules (10) connected end to end is disclosed. Each module of the attached traffic barrier modules (10) comprise, in combination: A) A module body (12) defining a hollow interior for accommodating water or other liquid and having a top, a bottom, opposed side walls (20) and opposed end walls (22). The module body (12) includes a passageway (60) passing through the hollow interior and separated from any water or other liquid in the hollow interior. The passageway (60) extends completely through the body (12) with openings in the opposed end walls (22). B) A first attachment means (46) connected to the module body (12) attaching the module body (12) to at least one adjacent module body (12) whereby the traffic barrier attains a first level of impact resistance performance when impacted by a vehicle; and C) A second attachment means (62) for selective connection to the module body (12) at a location on the module body (12) spaced from the first attachment means (46) or, alternatively, for removal from the module body (12). The second attachment means (62) when connected to the module body (12) extends completely through the passageway (60) and projects from both the opposed end walls (22) attaching the module body (12) to one or more adjacent module bodies (12). The traffic barrier attains a second level of impact resistance performance when impacted by a vehicle, which exceeds the first level of impact resistance performance, when using the second attachment (62) means in combination with the first attachment means (46).
Patent NZ-536290-A (NZ)
Title: Injecting a suspension of histologically compatible, autologous, passaged fibroblasts and muscle cells to treat urinary incontinence and vesicoureteral and oesophageal reflux
Inventor: MARKO OLGA
IPC: A61K35/34
Filed: 2003-04-22
Abstract: Described are compositions containing autologous, passaged fibroblasts and, optionally, autologous, passaged muscle cells, biodegradable acellular matrix components, and/or biodegradable acellular fillers, Also provided are methods for making the compositions, as well as devices and methods for administering the compositions to treat conditions such as urinary incontinence, vesicoureteral reflux, and gastroesophageal reflux.
Patent NZ-539833-A (NZ)
Title: Regulation of Type II collagen gene expression using specific and selective electrical and electromagnetic signals
Inventor: BRIGHTON CARL T
IPC: C12N5/077
Filed: 2003-10-07
Abstract: Disclosed are methods and devices for the regulation of type II collagen gene expression in cartilage cells via the application of specific and selective fields generated by specific and selective electric and electromagnetic signals in the treatment of diseased or injured articular cartilage. By gene expression is meant the up regulation or down regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein. Methods and devices are provided for the targeted treatment of injured or diseased cartilage tissue that include generating specific and selective electric and electromagnetic signals that generate specific and selective fields optimized for type II collagen gene expression and exposing cartilage tissue to the specific and selective fields generated by specific and selective signals so as to regulate type II collagen gene expression in such cartilage tissue. The resulting methods and devices are useful for the targeted treatment of osteoarthritis, rheumatoid arthritis, cartilage injury, and cartilage defects.
Patent NZ-541898-A (NZ)
Title: Uses of IL-23 antagonists for the manufacture of a medicament for the treatment of tumors
Inventor: OFT MARTIN
IPC: C07K16/24
Filed: 2004-03-09
Abstract: Disclosed is the use of an antagonist of IL-23 for the manufacture of a medicament for the treatment of tumors comprising tumor cells, wherein the antagonist of IL-23 comprises an antibody, or antigen binding fragment thereof, that specifically binds to p19 (SEQ ID NO:2). Specifically the tumor cells are colon cancer cells, ovarian cancer cells, breast cancer cells, or melanoma cells.
Patent NZ-544508-A (NZ)
Title: Polyvinyl butyral sheet with bifunctional surface modifying agent
Inventor: CHEN WENJIE
IPC: C08J7/04
Filed: 2004-06-07
Abstract: Disclosed is a polymer sheet comprising a bifunctional surface modifying agent disposed onto said polymer sheet, wherein said bifunctional surface modifying agent comprises an amphiphilic polyethylene-block-poly(ethylene glycol) polymer having the general formula: CH3CH2(CH2CH2)m-(OCH2CH2)nOH wherein m is 5 to 24 and n is 3 to 30.
Patent NZ-545659-A (NZ)
Title: Record carrier carrying a video signal and at least one additional information signal
Inventor: VAN GESTEL WILHELMUS JACOBUS
IPC: G11B20/12
Filed: 2004-08-25
Abstract: A record carrier is described carrying a video signal and at least one additional information signal, such as graphics or audio. The at least one additional information signal is meant to be reproduced simultaneously with said video signal. The record carrier further carries scheduling information indicating in which order parts of the at least one additional information signal or video signal have to be read from said record carrier. The scheduling information enables a reproducing device according to the invention to read parts of the video signal and the additional information signals such that no buffer overflow or underflow occurs. The size of the buffers in the apparatus can be reduced by means of the scheduling information. An apparatus for reproducing a video signal and at least one additional information signal and methods for recording and reproducing a video signal and at least one additional information signal on a record carrier are also provided.
Patent NZ-547160-A (NZ)
Title: N-acylsulfonamide apoptosis promoters
Inventor: BRUNCKO MILAN
IPC: A61K31/4439
Filed: 2004-11-12
Abstract: Disclosed are N-acylsulfonamide compounds of formula (I), wherein the substituents are as defined in the specification, which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating diseases such as bladder cancer, brain cancer, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukemia, colorectal cancer, esophageal cancer, hepatocellular cancer, lymphoblastic leukemia, follicular lymphoma, lymphoid malignancies of T-cell or B-cell origin, melanoma, myelogenous leukemia, myeloma, oral cancer, ovarian cancer, non-small cell lung cancer, prostate cancer, small cell lung cancer or spleen cancer.
Patent NZ-547983-A (NZ)
Title: Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
Inventor: BRAHMBHATT HIMANSHU
IPC: C12N15/85
Filed: 2004-12-08
Abstract: Provided is a targeted gene delivery method that comprises bringing bispecific ligands having specificity for a mammalian cell surface receptor capable of activating receptor-mediated endocytosis into contact with (a) bacterially derived minicells that contain a therapeutic nucleic acid sequence and (b) non-phagocytic mammalian cells, such that (i) said bispecific ligands cause said minicells to bind to said mammalian cells and (ii) said minicells are engulfed by said mammalian cells, which produce an expression product of said therapeutic nucleic acid sequence, with the proviso that any human cells are located ex vivo. Also provided are corresponding compositions and use of the compositions in the manufacture of medicaments wherein minicells contain a therapeutic nucleic acid molecule.
Patent NZ-552054-A (NZ)
Title: Container housing a hot or cold gel pack between two parts to keep the contents hot or cold respectively
Inventor: HARL KARA L
IPC: F25B43/00
Filed: 2005-06-21
Abstract: A container (100) containing a thermal mass (102) is disclosed. The container base (102) has a cavity with the thermal mass (108) with in it. An insert (103) is placed within the cavity such that the insert is in close proximity to the thermal source. A cover (104) is connected to the insert (103). The cover (104) and the insert (103) define a sealable compartment (106) for the storage of food items. The container base (102), the insert (103) and the cover (104) all have respective lips (110, 111, 112) that interconnected, each upper one connecting around the lower to connect the assembly together. The thermal mass (108) can act as either a heater or a cooler to help maintain the food items stored in the container at a desired temperature.
Patent NZ-561487-A (NZ)
Title: Cutter head for dredging soil and method for dredging by means of this cutter head
Inventor: TACK BRUNO
IPC: E02F3/24
Filed: 2006-02-17
Abstract: A cutter head for dredging soil, which is mountable to the ladder (2) of a suction dredger (1) for dredging soil, and connectable on a suction pipe (4) for removing loosened soil, the cutter head (10) comprising a cage-shaped support construction (11) which is mountable to a drivable rotation shaft (14) extending mainly in extension of the ladder and which has a circumferential surface provided with a number of cutting tools (20) for penetrating the soil, the cutting tools comprising a number of disc-shaped penetration bodies (21) of which the disc planes extend substantially perpendicular to the rotation shaft, so that they can transfer forces to the soil via their peripheral edges (22).
Patent NZ-563454-A (NZ)
Title: 2,4-diaminopyrimidine derivatives for inhibition of the JAK pathway
Inventor: SAMBAIAH THOTA
IPC: A61K31/505
Filed: 2006-06-08
Abstract: Disclosed are 2,4-diaryl substituted pyrimidine diamines with a sulphonamide substituted phenyl ring of formula (III), wherein the substituents are as defined in the specification. Also disclosed is their use in treating conditions in which modulation of the JAK pathway or inhibition of the JAK kinases, particularly JAK3, may be useful.
Patent NZ-565922-A (NZ)
Title: Container, closure means and use thereof
Inventor: ABRAHAMSSON PER
IPC: B65D33/16
Filed: 2006-09-15
Abstract: Disclosed is a container for liquid contents. The container includes a closure means for reclosing the container and a pouring spout portion made of two opposite container side walls and a removable end flap. The closure means includes a squeezing means permanently arranged on the pouring spout portion of the container. The squeezing means includes a first and a second leg which are joined to each other by a hinge, a connecting portion permanently connected to the pouring spout portion, and a joint means which is arranged between the hinge and the connecting portion to allow mutual relative turning of the first and the second leg in the joint means for opening and closing of the squeezing means. The squeezing means being movable between an open and a closed state. The squeezing means in its closed state being arranged to sandwich the side walls of the container.
Patent NZ-588969-A (NZ)
Title: Sleeping aid to alleviate snoring comprising a bridge that restricts the tongue from rearward movement
Inventor: GAY MAXWELL HAROLD
IPC: A61F5/56
Filed: 2010-11-02
Abstract: A sleeping aid device to alleviate snoring and/or sleep apnoea is disclosed. The device comprises upper mould (1) and a lower mould (2). The lower mould (2) is designed to locate the lower teeth and jaw of a user of the device in a more forward position that is usual, during sleep. The device is characterised by a bridge (4) that extends across the top of the user's tongue. The bridge restricts the tongue's movement by providing a barrier against its backward movement. This restriction of the backward movement of the tongue by the bridge (4) prevents the obstruction in the air passage by the tongue that has a tendency of moving back, while sleeping.
Patent NZ-598279-A (NZ)
Title: Improved fermentation of gaseous substrates
Inventor: TREVETHICK SIMON RICHARD
IPC: C12P7/54
Filed: 2010-09-03
Abstract: Disclosed is a process for the fermentation of a gaseous substrate comprising CO to produce one or more products the process comprising a) passing the gaseous substrate and a liquid media stream to a gas/liquid contact zone of a bioreactor and provide a fermentation broth b) passing the fermentation broth to a fermentation zone of the bioreactor operated at conditions to produce an effluent stream comprising products c) taking a slip stream of the fermentation broth from the fermentation zone and recycling it to the gas/liquid contact zone d) passing the effluent stream to a separation zone operated at conditions to produce a gaseous outlet stream comprising CO and a liquid outlet stream comprising products; e) passing the liquid outlet stream to a second separation zone operated at conditions to produce a purified product stream comprising ethanol and a recycle liquid stream comprising liquid media; and f) collecting the purified product stream.
Patent NZ-600912-A (NZ)
Title: Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection
Inventor: GOMEZ-ACEBO EDUARDO
IPC: A61K9/06
Filed: 2010-12-01
Abstract: 600912 Disclosed herein is a topical pharmaceutical composition which comprises a compound of formula (I), such as hydroxytyrosol, or a pharmaceutically acceptable salt, solvate, prodrug or isomer thereof, and a pharmaceutically acceptable carrier (I) wherein R1, R2 and R3 take different values, and the use of said composition as medicament in the prevention of sexually transmitted diseases (STDs) caused by fungi, bacteria or viruses, such as HIV-infection.
Patent NZ-603693-A (NZ)
Title: Method for loading oversized merchandise onto a container ship
Inventor: FERCHAUD ERIC
IPC: B66C1/16
Filed: 2011-05-03
Abstract: A standardized platform (1) provided with two crossbeams (11, 11’) at the front and rear ends thereof. The crossbeams extend beyond the side edges of the platform, whereby the ends of the beams can receive slings (24a-24d) enabling the assembly to be secured to container hoisting and handling means. It is thus possible to transport merchandise (21) that is both wider and longer than a standardized platform on the platform. The merchandise can thus be handled and loaded using hoisting and handling means for containers, i.e., at a reduced cost relative to oversized load transport.
Patent NZ-608304-A (NZ)
Title: Improved production of protein solutions from soy
Inventor: GREEN BRENT E
IPC: A23J3/16
Filed: 2011-08-18
Abstract: 608304 Disclosed is a process for the preparation of a soy protein solution, which includes: (a) extracting a soy protein source with an aqueous calcium salt solution to cause solubilization of soy protein from the soy protein source and to form an aqueous soy protein solution, (b) separating the aqueous soy protein solution from residual soy protein source, and either (c) within 20 minutes of step (b), (i) diluting the aqueous soy protein solution to a conductivity of less than 90 mS and (ii) adjusting the pH of the aqueous soy protein solution to a pH of 1.5 to 4.4 to produce an acidified soy protein solution having an absorbance of visible light at 600 nm (A600) of less than 0.055, or (d) within 40 minutes of step (b), (i) diluting the aqueous soy protein solution to a conductivity of less than 90 mS, (ii) adjusting the pH of the aqueous soy protein solution to a pH of 1.5 to 4.4 and (iii) heat treating the aqueous protein solution at a temperature of 70° to 160°C for 10 seconds to 60 minutes to produce an acidified soy protein solution having an absorbance of visible light at 600 nm (A600) of less than 0.055.